This inventor holds 1 USPTO granted patent. Top assignees: Celltrion Inc., Korea Advanced Institute of Science and Technology. Active years: 2023.
Company Filing History:
1 out of 35 
1 out of 2,781 
Years Active: 2023
Title: The Innovations of Sung Duk Jo
Introduction
Sung Duk Jo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of nanotechnology, particularly in the development of hybrid-type multi-lamellar nanostructures. His work focuses on enhancing the delivery and efficacy of epidermal growth factors.
Latest Patents
Sung Duk Jo holds a patent for a "Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same." This innovative patent describes a new type of hybrid nanostructure that boasts a high encapsulating efficiency for epidermal growth factors. The manufacturing process is designed to be simple, allowing for easy delivery into living bodies or cells while maintaining the physiological activity of the epidermal growth factor.
Career Highlights
Throughout his career, Sung Duk Jo has worked with notable organizations such as Celltrion Inc. and the Korea Advanced Institute of Science and Technology. His experience in these institutions has contributed to his expertise in the field of biomedical engineering and nanotechnology.
Collaborations
Sung Duk Jo has collaborated with esteemed colleagues, including Yoon Sung Nam and Bon Il Koo. These partnerships have furthered his research and development efforts in innovative technologies.
Conclusion
Sung Duk Jo's contributions to the field of nanotechnology and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the delivery of therapeutic agents, showcasing the potential of hybrid nanostructures in healthcare.